Nova Leah is a world leader in the provision of cybersecurity risk management solutions for medical device manufacturers and healthcare providers. With SelectEvidence™, Nova Leah provides medical device manufacturers with an intelligent, automated and traceable approach to cybersecurity risk management. Now, with SelectEvaluateⓇ, Nova Leah is transforming medical device third party risk management and cybersecurity monitoring across the healthcare cybersecurity supply chain. SelectEvaluateⓇ is launching in October 2023.
